Children deserve simple, short, safe, and effective treatment for rifampicin-resistant tuberculosis-Reference-Cited by-同舟云学术

Children deserve simple, short, safe, and effective treatment for rifampicin-resistant tuberculosis

Published:2023-07 Issue:7 Volume:23 Page:778-780
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Garcia-Prats Anthony J,Hoddinott Graeme,Howell Pauline,Hughes Jennifer,Jean-Philippe Patrick,Kim Soyeon,Palmer Megan,Schaaf H Simon,Seddon James A,Svensson Elin,Hesseling Anneke C

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference8 articles.

1. Bedaquiline–pretomanid–linezolid regimens for drug-resistant tuberculosis;Conradie;N Engl J Med,2022

2. Delamanid or pretomanid? A Solomonic judgement!;Mudde;J Antimicrob Chemother,2022

3. Conradie F. High rate of successful outcomes treating RR-TB with a delamanid–bedaquiline regimen in BEAT Tuberculosis: an interim analysis. Union World Conference on Lung Health 2022; Nov 8–11, 2022 (LBTB-2074-11).

4. Bedaquiline, delamanid, linezolid and clofazimine for treatment of pre-extensively drug-resistant tuberculosis;Padmapriyadarsini;Clin Infect Dis,2022

5. Daily dosing for bedaquiline in patients with tuberculosis;Salinger;Antimicrob Agents Chemother,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmaceutical cost dynamics for the treatment of rifampicin-resistant tuberculosis in children and adolescents in South Africa, India, and the Philippines;PLOS ONE;2024-07-23

2. Acceptability of clofazimine capsules in children and adolescents with rifampicin-resistant TB;The International Journal of Tuberculosis and Lung Disease;2024-05-01

3. Current Treatment of Drug-Resistant Tuberculosis in Children;Indian Journal of Pediatrics;2023-11-23

4. Tuberculosis in children and adolescents: a forgotten group in a forgotten disease;The Challenge of Tuberculosis in the 21st Century;2023-09-01